ONLINE DATABASE SEARCH -
HIV-LS-367-MEMO
1.
60069 HIV-LS-367;
SCIFINDER-HIV-1/29/2007
Hiv reverse transcriptase inhibitors
Saggar, Sandeep A, Sisko, John T, Tucker, Thomas J, Tynebor, Robert M,
Su, Dai-Shi, and Anthony, Neville J
PATENT: US
2007021442 ISSUE DATE: 20070125
APPLICATION: 2006-29133 PP:
72pp.
ASSIGNEE:
(USA)
View Data on the NIAID Therapeutics Website
HYPERLINK:
2.
60070 HIV-LS-367;
PUBMED-HIV-2/5/2007
A Mutation in Alpha Helix 3
of CA Renders Human Immunodeficiency Virus Type 1 Cyclosporin A-Resistant and
Dependent: Rescue by a Second-Site Substitution in a Distal Region of
CA
Yang, R and Aiken, C
J Virol 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
3.
60071 HIV-LS-367;
PUBMED-HIV-2/5/2007
Simultaneous determination of 1,5-dicaffeoylquinic acid and its active
metabolites in human plasma by liquid chromatography-tandem mass spectrometry
for pharmacokinetic studies
Gu, R, Dou, G, Wang, J, Dong, J, and Meng, Z
J Chromatogr B Analyt Technol Biomed Life Sci
2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
4.
60072 HIV-LS-367;
PUBMED-HIV-2/5/2007
Safety and Pharmacokinetics of Brecanavir, a Novel HIV-1 Protease
Inhibitor, Following Repeat Administration with and without Ritonavir in Healthy
Adult Subjects
Reddy, SY, Ford, SL, Anderson, MT, Murray, SC, Ng-Cashin, J, and Johnson,
MA
Antimicrob Agents Chemother 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
5.
60073 HIV-LS-367;
SCIFINDER-HIV-1/29/2007
Preparation of aryl phosphate derivatives of d4T having activity against
resistant HIV strains
Uckun, Fatih M
PATENT: US
2007015733 ISSUE DATE: 20070118
APPLICATION: 2006-27757 PP:
42pp., Cont.-in-part of U.S. Ser. No. 275,102.
ASSIGNEE: (Parker Hughes
Institute, USA
View Data on the NIAID Therapeutics Website
HYPERLINK:
6.
60074 HIV-LS-367;
PUBMED-HIV-2/5/2007
HIV-1 integration is inhibited by stimulation of the VPAC2 neuroendocrine
receptor
Bokaei, PB, Ma, XZ, Sakac, D, and Branch, DR
Virology 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
7.
60075 HIV-LS-367;
SCIFINDER-HIV-1/29/2007
Alkenyldiarylmethanes, fused analogs and syntheses
thereof
Cushman, Mark S and Deng, Bo-Liang
PATENT: WO
2007005531 ISSUE DATE: 20070111
APPLICATION: 2006 PP:
72pp.
ASSIGNEE: (Purdue Research
Foundation, USA
View Data on the NIAID Therapeutics Website
HYPERLINK:
8.
60076 HIV-LS-367;
PUBMED-HIV-2/5/2007
Inhibition of HIV-1 Infection of Human CD4+ T Cells by Microbial HSP70
and the Peptide Epitope 407-426
Babaahmady, K, Oehlmann, W, Singh, M, and Lehner, T
J Virol 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
9.
60077 HIV-LS-367;
SCIFINDER-HIV-1/29/2007
Carbohydrate-binding agents efficiently prevent dendritic cell-specific
intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN)-directed HIV-1
transmission to T lymphocytes
Balzarini, Jan, Van Herrewege, Yven, Vermeire, Kurt, Vanham, Guido, and
Schols, Dominique
Molecular Pharmacology 2007.
71(1): 3-11
View Data on the NIAID Therapeutics Website
HYPERLINK:
10.
60078 HIV-LS-367;
PUBMED-HIV-2/5/2007
Broad-spectrum anti-HIV Potential of a Peptide HIV-1 Entry
Inhibitor
Cocklin, S, Gopi, H, Querido, B, Nimmagadda, M, Kuriakose, S, Cicala, C,
Ajith, S, Baxter, S, Arthos, J, Martin-Garcia, J, and Chaiken,
IM
J Virol 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
11.
60079 HIV-LS-367;
SCIFINDER-HIV-1/29/2007
Oxazolidinecarboxamides as HIV-1 protease inhibitors, and methods of
making and using them
Rana, Tariq M, Ali, Akbar, Cao, Hong, Sai, Kiran Kumar Reddy Ga, and
Anjum, Saima Ghafoor
PATENT: WO
2007002173 ISSUE DATE: 20070104
APPLICATION: 2006 PP:
194pp., which which
ASSIGNEE: (University of
Massachusetts, USA
View Data on the NIAID Therapeutics Website
HYPERLINK:
12.
60080 HIV-LS-367;
SCIFINDER-HIV-1/29/2007
Use of modified U1 snRNAs to inhibit HIV-1 replication
Sajic R, Lee K, Asai K, Sakac D, Branch D R, Upton C, and Cochrane
A
Nucleic Acids Res 2007.
35(1): 247-55.
View Data on the NIAID Therapeutics Website
HYPERLINK:
13.
60081 HIV-LS-367;
PUBMED-HIV-2/5/2007
3'-Azido-3'-deoxythymidine-(5')-tetraphospho-(5')-adenosine, the product
of ATP-mediated excision of chain-terminating AZTMP, is a potent
chain-terminating substrate for HIV-1 reverse transcriptase
Dharmasena, S, Pongracz, Z, Arnold, E, Sarafianos, SG, and Parniak,
MA
Biochemistry 2007.
46(3): 828-36
View Data on the NIAID Therapeutics Website
HYPERLINK:
14.
60082 HIV-LS-367;
SCIFINDER-HIV-1/29/2007
Lysis of human immunodeficiency virus type 1 by a specific secreted human
phospholipase A2
Kim Jae-Ouk, Chakrabarti Bimal K, Guha-Niyogi Anuradha, Louder Mark K,
Mascola John R, Ganesh Lakshmanan, and Nabel Gary J
J Virol 2007. 81(3):
1444-50.
View Data on the NIAID Therapeutics Website
HYPERLINK:
15.
60083 HIV-LS-367;
PUBMED-HIV-2/5/2007
Susceptibility of HIV-1 non-B subtypes and recombinant variants to
Enfuvirtide
Holguin, A, Faudon, JL, Labernardiere, JL, and Soriano,
V
J Clin Virol 2007.
38(2): 176-80
View Data on the NIAID Therapeutics Website
HYPERLINK:
16.
60084 HIV-LS-367;
PUBMED-HIV-2/5/2007
Plasma adenosine deaminase activity among HIV1 Clade C seropositives:
Relation to CD4 T cell population and antiretroviral therapy
Chittiprol, S, Satishchandra, P, Bhimasenarao, RS, Rangaswamy, GR,
Sureshbabu, SV, Subbakrishna, DK, Satish, KS, Desai, A, Ravi, V, and Shetty,
KT
Clin Chim Acta 2007.
377(1-2): 133-137
View Data on the NIAID Therapeutics Website
HYPERLINK:
17.
60085 HIV-LS-367;
SCIFINDER-HIV-1/29/2007
Preparation of phosphono-pent-2-en-1-yl nucleosides and analogs as
antiviral and antitumor agents
Hostetler, Karl Y, Beadle, James R, and Choo,
Hyunah
PATENT: WO
2006137953 ISSUE DATE: 20061228
APPLICATION: 2006 PP:
67pp.
ASSIGNEE: (The Regents of
the Univerisity of California, USA
View Data on the NIAID Therapeutics Website
HYPERLINK:
18.
60086 HIV-LS-367;
WOS-HIV-1/28/2007
Design of anti-HIV Ligands by means of minimal topological difference
(MTD) method
Duda-Seiman, C, Duda-Seiman, D, Dragos, D, Medeleanu, M, Careja, V, Putz,
MV, Lacrama, AM, Chiriac, A, Nutiu, R, and Ciubotariu, D
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2006. 7(11): 537-555, 19
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243258800006
19.
60087 HIV-LS-367;
WOS-HIV-1/28/2007
Virostatics: A new class of anti-HIV drugs
Lori, F, Foli, A, Kelly, LM, and Lisziewicz, J
CURRENT MEDICINAL CHEMISTRY 2007. 14(2): 233-241, 9
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243248700010
20.
60088 HIV-LS-367;
WOS-HIV-2/4/2007
Hyperbranched molecular structures with potential antiviral activity:
Derivatives of 5,6-dihydroxyindole-2-carboxylic acid
Sechi, M, Casu, F, Campesi, I, Fiori, S, and Mariani,
A
MOLECULES 2006.
11(12): 968-977, 10
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243402400004
21.
60089 HIV-LS-367;
WOS-HIV-2/4/2007
Syntheses and anti-AIDS activities of polyrotaxane-3 '-azido-3
'-deoxythymidine conjugates
Chung, I, Ha, CS, Lee, JK, Lee, CK, and Xie, D
MACROMOLECULAR RESEARCH 2006. 14(6): 668-672, 5
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243353700016
22.
60090 HIV-LS-367;
WOS-HIV-2/4/2007
Synthesis of 2,3,4,7-tetrahydro-1H-azepines as privileged ligand
scaffolds for the design of aspartic protease inhibitors via a ring-closing
metathesis approach
Brass, S, Chan, NS, Gerlach, C, Luksch, T, Bottcher, J, and Diederich,
WE
JOURNAL OF ORGANOMETALLIC CHEMISTRY 2006. 691(24-25): 5406-5422,
17
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243267200034
23.
60091 HIV-LS-367;
WOS-HIV-2/4/2007
Development of low molecular weight CXCR4 antagonists by exploratory
structural tuning of cyclic tetra- and pentapeptide-scaffolds towards the
treatment of HIV infection, cancer metastasis and rheumatoid
arthritis
Tamamura, H, Tsutsumi, H, Masuno, H, and Fujii, N
CURRENT MEDICINAL CHEMISTRY 2007. 14(1): 93-102, 10
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243248500006
24.
60092 HIV-LS-367;
WOS-HIV-2/4/2007
Screening and selecting for optimized antiretroviral drugs: rising to the
challenge of drug resistance
de Bethune, MP and Hertogs, K
CURRENT MEDICAL RESEARCH AND OPINION 2006. 22(12): 2603-2612,
10
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243238900030
25.
60093 HIV-LS-367;
WOS-HIV-2/4/2007
Short partially double-stranded oligodeoxynucleotide induces reverse
transcriptase/RNase H-mediated cleavage of HIV RNA and contributes to abrogation
of infectivity of virions
Matskevich, AA, Ziogas, A, Heinrich, J, Quast, SA, and Moelling,
K
AIDS RESEARCH AND HUMAN RETROVIRUSES 2006. 22(12): 1220-1230,
11
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243398800003
26.
60094 HIV-LS-367;
WOS-HIV-2/4/2007
Resistance mutational analysis of HIV type 1 subtype C among rural South
African drug-naive patients prior to large-scale availability of
antiretrovirals
Bessong, PO, Mphahlele, J, Choge, IA, Obi, LC, Morris, L, Hammarskjold,
ML, and Rekosh, DM
AIDS RESEARCH AND HUMAN RETROVIRUSES 2006. 22(12): 1306-1312,
7
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243398800015
27.
60095 HIV-LS-367;
WOS-HIV-2/4/2007
Structural studies of algal lectins with anti-HIV
activity
Ziolkowska, NE and Wlodawer, A
ACTA BIOCHIMICA POLONICA 2006. 53(4): 617-626, 10
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243239400001